Editorial Policy

Editorial Independence

Our editorial content is produced independently of any commercial relationships. Sponsors and partners have no influence over:

• Which peptides we cover
• How we grade evidence
• What conclusions we draw from research
• Our editorial priorities or publishing schedule

Accuracy Standards

We maintain accuracy through:

• Citation verification — Every cited source is verified to exist and accurately represent the claim
• Automated checks — Our publishing system validates that all cited PMIDs, DOIs, and trial IDs exist
• Human review — All content passes editorial review before publication
• Open corrections — We promptly correct errors and note corrections transparently

Content Guidelines

What We Include

• Peer-reviewed research findings
• Clinical trial data and regulatory information
• Mechanistic explanations from established science
• Safety signals and adverse event reports
• Clearly labeled inferences with confidence levels

What We Exclude

• Dosing protocols or administration instructions
• Sourcing, purchasing, or vendor information
• Personal medical advice or recommendations
• Unsubstantiated claims or anecdotal evidence presented as fact
• Content that could facilitate misuse

Language & Tone

We write for an educated general audience. Our content is:

• Neutral — No promotional language or hype
• Precise — Clear about what evidence shows and doesn't show
• Accessible — Technical terms are explained; jargon is minimized
• Honest — We acknowledge uncertainty and limitations

Corrections Policy

When we make errors, we correct them transparently:

• Minor corrections (typos, formatting) are made without notation
• Substantive corrections are noted at the bottom of the affected page
• Significant errors affecting conclusions trigger a prominent correction notice

Conflicts of Interest

We disclose any relevant conflicts of interest. Our team members do not:

• Hold financial interests in peptide manufacturers or distributors
• Accept payment from sources we cover for favorable coverage
• Allow sponsors to review or approve editorial content before publication

Last updated: January 2026